ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY
Clinical trials for ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY explained in plain language.
Never miss a new study
Get alerted when new ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY trials appear
Sign up with your email to follow new studies for ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a targeted pill tame dangerous heart rhythms in genetic heart disease?
Disease control Recruiting nowThis study tests an experimental drug called tideglusib in people with a genetic heart condition that causes dangerous heart rhythms. The goal is to see if the drug can reduce the number of extra heartbeats and prevent serious rhythm events. About 120 adults with a confirmed gene…
Matched conditions: ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY
Phase: PHASE2 • Sponsor: Hamilton Health Sciences Corporation • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New PET scan could spot hidden heart scarring in rare condition
Diagnosis Recruiting nowThis study is testing a new imaging method called FAPI PET/CT to see if it can better detect scarring in the heart muscle of people with arrhythmogenic right ventricular cardiomyopathy (ARVC), a rare inherited heart condition that can lead to dangerous heart rhythms and sudden ca…
Matched conditions: ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY
Phase: NA • Sponsor: Istanbul University - Cerrahpasa • Aim: Diagnosis
Last updated May 15, 2026 11:57 UTC
-
Can ARVC patients exercise safely? new study aims to find out
Knowledge-focused Recruiting nowThis study looks at how different types and intensities of exercise affect heart rhythm in people with arrhythmogenic right ventricular cardiomyopathy (ARVC). Researchers will measure extra heartbeats and heart workload during activities like walking or biking. The goal is to cre…
Matched conditions: ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY
Phase: NA • Sponsor: Swiss Federal Institute of Technology • Aim: Knowledge-focused
Last updated May 17, 2026 10:09 UTC
-
Heart gene hunt: 1,000 volunteers sought to unlock sudden death mystery
Knowledge-focused Recruiting nowThis study is looking for 1,000 people with a genetic heart condition called arrhythmogenic cardiomyopathy (AVC) or their family members. The goal is to discover new genes and blood markers that can predict who will get the disease, how it will progress, and who is at risk for da…
Matched conditions: ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated May 06, 2026 16:14 UTC